Carbamazepine suppresses methamphetamine-induced fos expression in a regionally specific manner in the rat brain: Possible neural substrates responsible for antimanic effects of mood stabilizers

Neuropsychopharmacology

Volumn 22, Issue 5, 2000, Pages 530-537

  Lee, Youmei ^a   Hamamura, Takashi ^a   Ohashi, Kazuyo ^a   Miki, Masato ^a   Fujiwara, Yutaka ^b   Kuroda, Shigetoshi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Takaoka Hospital   (Japan)

Author keywords

Carbamazepine; Caudate putamen; Fos; Manic state; Methamphetamine; Nucleus accumbens

Indexed keywords

CARBAMAZEPINE; METHAMPHETAMINE; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CAUDATE NUCLEUS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MANIA; MOOD; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; RAT;

AMPHETAMINE-RELATED DISORDERS; ANIMALS; ANTIMANIC AGENTS; BIPOLAR DISORDER; BODY WEIGHT; BRAIN; CARBAMAZEPINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG ADMINISTRATION SCHEDULE; MALE; METHAMPHETAMINE; NEOSTRIATUM; NUCLEUS ACCUMBENS; PROTO-ONCOGENE PROTEINS C-FOS; RATS;

EID: 0034060209     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00142-6     Document Type: Article

References (46)

1. Baptista T., Weiss S.R.B., Post M. Carbamazepine attenuates cocaine-induced increases in dopamine in the nucleus accumbens. An in vivo dialysis study Eur J Pharmacol. 236:1993;39-42.
2. Barraco R.A., Martens K.A., Parizon M., Normile H.J. Adenosine A2a receptors in the nucleus accumbens mediates locomotor depression. Brain Res Bull. 31:1993;397-404.
3. Barros H.M.T., Braz S., Leite J.R. Effect of carbamazepine on dopamine release and reuptake in rat striatal slice. Epilepsia. 27:1986;534-537.
4. Brauer L.H., de Wit H. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers. Biol Psychiat. 39:1996;26-32.
5. Brauer L.H., de Wit H. High dose pimozide does not block amphetamine-induced euphoria in normal volunteers. Pharmacol Biochem Behav. 56:1997;265-272.
6. Collis M.G., Hourani S.M.O. Adenosine receptor subtypes. Trends Pharmacol Sci. 14:1993;360-366.
7. Daval J.-L., Deckert J., Weiss S.R.B., Post R.M., Marangos P.J. Up-regulation of adenosine A1 receptors and forskolin binding sites following chronic treatment with caffein or carbamazepine. A quantitative autoradiographic study Epilepsia. 30:1989;26-33.
8. Dixon A.K., Gubitz A.K., Sirinathsinghji D.J.S., Richardson P.J. Tissue distribution of adrenosine receptor mRNAs in the rat. Br J Pharmacol. 118:1996;1461-1468.
9. Dragunow M., Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods. 29:1989;261-265.
10. Elphick M. Effects of carbamazepine on dopamine function in rodents. Psychopharmacology. 99:1989;532-536.
11. 2 receptors. Studies with the putative selective adenosine antagonists PD 115, 199 and PD 116, 948 Psychopharmacology. 100:1990;522-529.
12. Emilien G., Maloteaux J.M., Seghers M., Charles G. Lithium compared to valproic acid and carbamazepine in the treatment of mania. A statistical meta-analysis Eur Neuropsychopharmacol. 6:1996;245-252.
13. Fastbom J., Pazos A., Palacios J.M. The distribution of adenosine A1 receptors and 5′-nucleotidase in the brain of some commonly used experimental animals. Neuroscience. 22:1987;813-826.
14. 2b receptors. Pharmacol Rev. 49:1997;381-402.
15. Fibiger H.C., Phillips A.G. Reward, motivation, cognition. Psychobiology of mesotelencephalic dopamine systems Mountcastle V.B. Handbook of Physiology. The Nervous System, vol. 4, Intrinsic Regulatory Systems of the Brain:1986;647-675 American Physiological Society, Bethesda, MD.
16. Fujiwara Y., Sato M., Otsuki S. Interaction of carbamazepine and other drugs with adenosine A1 and A2 receptors. Psychopharmacology. 90:1986;332-335.
17. Goodman R.R., Synder S.H. Autoradiographic localization of adenosine receptors in rat brain using [3H] cyclohexyladenosine. J Neurosci. 9:1982;1230-1241.
18. Graybiel A.M., Moratalla R., Robertson H.A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-martix compartments and limbic subdivisions of the striatum. Proc Natl Acad Sci USA. 87:1990;6912-6916.
19. Hamamura T., Lee Y., Fujiwara Y., Kuroda S. Serotonin 1A receptors agonists induce Fos protein expression in the locus coeruleus of the conscious rat. Brain Res. 759:1997;156-159.
20. Heimer L., de Olmos J., Alheid G.F., Zaborsky L. Perestroika in the basal forebrain. Opening the border between neurology and psychiatry Prog Brain Res. 87:1991;109-165.
21. 3H]-CGS 21680. Eur J Pharmacol. 168:1989;243-246.
22. Kuczenski R., Segal D.S. Neurochemistry of Amphetamine. Cho A.K., Segal D.S. Amphetamine and Its Analogs. Psychopharmacology, Toxicology, and Abuse:1994;81-113 Academic Press, San Diego.
23. Lee Y., Hamamura T., Ohashi K., Fujiwara Y., Kuroda S. The effect of lithium on methamphetamine-induced regional Fos protein expression in the rat brain. NeuroReport. 10:1999;895-900.
24. Le Moine C., Svenningsson P., Fredhoim B.B. Adenosine-dopamine interactions in the brain. Neuroscience. 51:1992;513-532.
25. Marangos P.J., Weiss S.R.B., Montgomery Patel J., Narang P.K., Cappabianca A.M., Post R.M. Chronic carbamazepine treatment increases brain adenosine receptor. Epilepsia. 26:1985;493-498.
26. Marangos P.J., Montgomery Weiss S.R.B., Patel J., Post R.M. Persistent up-regulation of brain adenosine receptor in response to chronic carbamazepine treatment. Clin Neurophamacol. 10:1987;443-448.
27. Mogenson G.J., Jones D.L., Yim C.H. From motivation to action. Functional interface between the limbic system and the motor system Prog Neurobiol. 14:1980;69-97.
28. Morgan J.I., Curran T. Stimulus-transcription coupling in the nervous system. Involvement of the inducible proto-oncogenes fos and jun Annu Rev Neurosci. 14:1991;421-451.
29. Okada M., Hirano T., Mizuno K., Chiba T., Kawata Y., Kiryu K., Wada K., Tasaki H., Kaneko S. Biphasic effects of carbamazepine on the dopaminergic system in rat striatum and hypocampus. Epilepsy Res. 28:1997;143-153. a.
30. Okada M., Kiryu K., Kawata Y., Mizuno K., Wada K., Tasaki H., Kaneko S. Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis. Eur J Pharmacol. 321:1997;181-188. b.
31. 3H]-CGS 21680 as a ligand. Naunyn Schmiedebergs Arch Pharmacol. 342:1990;85-89.
32. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed:1986;Academic Press, San Diego.
33. Post R.M. Mechanisms of action of carbamazepine and related anticonvulsants in affective illness. Meltzer H.Y., Bunney W.E. Jr. Psychopharmacology. 1987;567-576 Raven Press, New York.
34. Post R.M., Ballenger J.C. Biochemical and pharmacological studies. Manic-Depressive Psychosis:1990;416-502 Oxford University Press, New York.
35. Post R.M., Weiss S.R.B., Chung D., Ketter T.A. Mechanism of action of carbamazepine in seizure and affective disorders. Joffe R.T., Calabrese J.R. Anticonvulsants in Mood Disorders. 1994;43-92 Dekker, New York.
36. Robbins T.W., Everitt B.J. Neurobehavioral mechanisms of reward and motivation. Curr Opin Neurobiol. 6:1996;228-236.
37. Robbins T.W., Sahakian B.J. Animal models of mania. Belmaker H.et al. Mania. An Evolving Concept:1980;143-216 SP Medical & Scientific Books, New York.
38. Robertson H.A., Peterson M.R., Murphy K., Robertson G.S. D1 dopamine receptor agonists selectively activate striatal c-fos independent of rotational behavior. Brain Res. 503:1989;346-349.
39. Sagar S.M., Sharp F.R., Curran T. Expression of c-fos protein in brain. Metabolic mapping at the cellular level Science. 240:1988;1328-1331.
40. Shu S.Y., Ju G., Fan L.Z. The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci Lett. 85:1988;169-171.
41. Smith R.C., Davis J.M. Comparative effects of d-amphetamine, l-amphetamine, and methylphenidate on mood in man. Psychopharmacology. 53:1977;1-12.
42. Stoof J.C., Kebabian J.W. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature. 294:1981;366-368.
43. 2a agonists on amphetamine-induced locomotion and c-Fos in striatum and nucleus accumbens. Brain Res. 707:1996;75-80.
44. Waldmeier P.C., Baumann P.A., Fehr B., De Herdt P., Maitre L. Carbamazepine decreases catecholamine turnover in the rat brain. J Pharmacol Exp Ther. 231:1984;166-172.
45. Weiss S.R.B., Nguyen T., Rubinow D.R., Helke C.J., Narang P.K., Jacobowitz D.M. Lack of effect of chronic carbamazepine on brain somatostatin in rat. J Neural Transm. 68:1987;325-333.
46. Zahm D.S., Brog J.S. On the significance of subterritories in the accumbens part of the rat ventral striatum. Neuroscience. 50:1992;751-767.